BioPorto (Denmark) Today
| BIOPOR Stock | DKK 1.48 0.01 0.68% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
BioPorto is trading at 1.48 as of the 18th of March 2025, a 0.68% increase since the beginning of the trading day. The stock's open price was 1.47. BioPorto has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies for healthcare professionals in clinical and research settings worldwide. BioPorto AS was founded in 2000 and is headquartered in Hellerup, Denmark. BioPorto operates under Diagnostics Research classification in Denmark and is traded on Copenhagen Stock Exchange. The company has 334.68 M outstanding shares. More on BioPorto
Moving together with BioPorto Stock
Moving against BioPorto Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioPorto Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioPorto's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioPorto or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) |
BioPorto (BIOPOR) is traded on Copenhagen Exchange in Denmark and employs 31 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 841.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto's market, we take the total number of its shares issued and multiply it by BioPorto's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioPorto operates under Biotechnology sector and is part of Health Care industry. The entity has 334.68 M outstanding shares.
BioPorto has accumulated about 32.21 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check BioPorto Probability Of Bankruptcy
Ownership AllocationBioPorto holds a total of 334.68 Million outstanding shares. BioPorto shows 19.84 percent of its outstanding shares held by insiders and 8.6 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioPorto Ownership Details
BioPorto Risk Profiles
Although BioPorto's alpha and beta are two of the key measurements used to evaluate BioPorto's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.05 | |||
| Standard Deviation | 2.94 | |||
| Variance | 8.63 | |||
| Risk Adjusted Performance | (0.07) |
BioPorto Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioPorto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
BioPorto Corporate Management
Elected by the shareholders, the BioPorto's board of directors comprises two types of representatives: BioPorto inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioPorto. The board's role is to monitor BioPorto's management team and ensure that shareholders' interests are well served. BioPorto's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioPorto's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Bird | Chief Officer | Profile | |
| Neil CPA | Ex CFO | Profile | |
| Jennifer Zonderman | VP Commercialization | Profile | |
| Lars Uttenthal | Chief Officer | Profile | |
| Gry Larsen | G Counsel | Profile | |
| Nis Kruse | Ex APAC | Profile | |
| Anthony Pare | Chief Officer | Profile |
Other Information on Investing in BioPorto Stock
BioPorto financial ratios help investors to determine whether BioPorto Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioPorto with respect to the benefits of owning BioPorto security.